Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Risk Reduction Behavior × Gynecologic × Clear all

Status

Unknown 1 Completed 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Gynecologic 1 Breast 1

Conditions

Ovarian Neoplasms 359 Uterine Cervical Neoplasms 342 Endometrial Neoplasms 172 Carcinoma, Ovarian Epithelial 88 Fallopian Tube Neoplasms 68 Breast Neoplasms 61 Uterine Cervical Dysplasia 59 Neoplasms 47 Stomach Neoplasms 31 Pancreatic Neoplasms 31 Recurrence 29 Colorectal Neoplasms 28 Papillomavirus Infections 25 Vulvar Neoplasms 24 Uterine Neoplasms 24 Peritoneal Neoplasms 24 Lung Neoplasms 22 Esophageal Neoplasms 21 Prostatic Neoplasms 20 Melanoma 20 Urinary Bladder Neoplasms 18 Colonic Neoplasms 18 Head and Neck Neoplasms 17 Gynecologic Cancer 16 Sarcoma 15 Ovarian Cysts 14 Neoplasm Metastasis 14 Endometrial Hyperplasia 14 Carcinoma, Non-Small-Cell Lung 14 Squamous Intraepithelial Lesions 13

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04470921 2024-01-26

STOPOVCA

Radboud University Medical Center

10,000 enrolled

Ovarian Neoplasms, Risk Reduction Behavior

Data powered by HemOnc (CC BY 4.0) Colophon ⚡